DALLAS, July 16 TX-RSCI-AnnouncesSAB
DALLAS, July 16 /PRNewswire/ -- The Repair Stem Cell Institute LLC
(RSCI; www.RepairStemCells.org), a Dallas, Texas-based stem cell global public
affairs organization, today announced the formation of a new Science Advisory
Board (SAB) consisting of some of the world's leading stem cell medical,
science and research professionals. RSCI was founded in April 2008 and has
offices located in Washington, D.C. and Bangkok.
According to Don Margolis, RSCI chairman and founder
(donmargolis@gmail.com; 214-556-6377), "RSCI's new Science Advisory Board has
been created to provide the general public with the latest repair stem cell
research and therapeutic innovations. Each of these five SAB members are
active stem cell leaders who are not only researching, but successfully
delivering cells to patients suffering from heart disease, diabetes, spinal
cord injuries, neurological disorders, and 100+ other incapacitating
conditions, all of which are covered at www.RepairStemCells.org - click-on
'Diseases Treated.'"
RSCI's world-leading stem cell treatment experts are as follows:
SAB chairman Dr. Kitipan V. Arom, M.D., Ph.D., FACS, FACC, FACCP, FRCST,
established an innovative stem cell treatment program at Bangkok Heart
Hospital (BHH) and may be the only doctor in the world to successfully inject
RSC directly into the heart muscles of more than 120 late-stage heart
patients. Dr. Arom, associate professor of surgery and chief cardiothoracic
surgeon at BHH, previously served in many capacities with several hospitals in
the Minneapolis/St. Paul area, founded the Minneapolis Heart Institute &
Minneapolis Heart Institution Foundation and is currently the President of the
Society of Thoracic Surgeons of Thailand.
Dr. Roberto Jorge Fernandez - Vina, M.D. is known for his innumerable
cardiology advances, is an authority on the utilization of RSC treatment of
Type-2 diabetes and is the first and only known person with a successful
clinical trial on helping Type-2 diabetes with repair stem cell treatment. He
has treated hundreds of patients with RSC for heart disease, Type-2 diabetes
and emphysema; both in his clinic in Argentina and in clinics in other Latin
American countries. He is on the verge of another discovery for the most
difficult to treat common disease of all, diabetes Type-1.
Professor Shimon Slavin, M.D., an expert bone marrow transplantation
scientist and clinician, is world-famous for his innovative clinical
application of cell-mediated immunotherapy for the treatment of hematological
malignancies, solid tumors, immune disorders and a broad spectrum of
non-malignant conditions treatable by stem cell transplantation. He and his
team are the first known in the world to treat multiple sclerosis and
amyotropic lateral sclerosis patients by injecting their spinal fluid with
large numbers of repair stem cells (mesenchymal stromal stem cells) taken from
their bone marrow and multiplied in culture. Dr. Slavin is the medical &
scientific director of the newly established International Center for Cell
Therapy & Cancer (ICTC) at the Tel Aviv (Sourasky) Medical Center in Israel.
Dr. Carlos Lima, M.D., one of the foremost neuropathologist experts in RSC
treatments, rejected traditional bone marrow stem cells as a too limited
source for the neurological stem cells required to repair injured spinal
cords. Using olfactory stem cells harvested from the patients' own nose, Dr.
Lima transplants the cells at the spinal cord break utilizing the successful
OMA transplant surgical procedure he developed. Dr. Lima is the only doctor in
the world whose treatments have created the neurological redevelopment
required to allow some paraplegics to engage in extensive rehabilitation
therapy, rise from their wheelchairs and walk.
Dr. Zannos G. Grekos, M.D., Director of Cardiology & Vascular Disease at
Metropolitan Hospital - Santiago, Dominican Republic, is a RSC innovator. In
April 2008 he saved a young meningitis patient's arms and legs from amputation
and in May he saved a young cardiomyopathy patient with serious complications
by developing a new multi-faceted comprehensive repair stem cell treatment
procedure. He has collaborated with the major treatment centers in Asia, been
active in both the development of research and treatment protocols and
consults with patients throughout the world. Dr. Grekos utilizes RSC to treat
pulmonary hypertension and fibrosis, heart and peripheral vascular diseases
and diabetes.
Visit www.RepairStemCells.org and click-on "Science Advisory Board" for
more information about each of these five leaders, now treating over 100
different medical conditions.
SOURCE The Repair Stem Cell Institute LLC
